Pfizer Ltd. (NSE: PFIZER, BSE: 500680) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹16,525 Cr, it ranks #396 by market cap among the 6,189 Indian listed companies on FinBizNet, and #7 of 63 in Pharmaceuticals. At ₹3,612.30 (as of 26 Oct 2026), the share price is 32.4% below its 52-week high of ₹5,346.00 and 0.6% above its 52-week low of ₹3,589.00. The share price is down 32.1% over one year and down 21.9% over three months.
| Current Price | ₹3,612.30 |
|---|---|
| Market Cap | ₹16,525 Cr |
| NSE Symbol | PFIZER |
| BSE Code | 500680 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 22.9 |
| Return on Equity | 17.16% |
| Return on Assets | 10.77% |
| 52-Week Range | ₹3,589.00 – ₹5,346.00 |
| 1-Year Price Change | -32.1% |
| 3-Month Price Change | -21.9% |
| Beta (1Y) | 0.34 |
| Dividend Yield | 2.08% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.pfizerltd.co.in |
| Revenue | ₹653 Cr |
|---|---|
| Net Profit | ₹204 Cr |
| Net Margin | 31.3% |
| EPS (Basic) | ₹44.69 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
1. Pharmaceuticals-This segment provides various pharmaceutical products. It offers products in various therapeutic areas, including women healthcare, respiratory, multivitamins, cardiovascular, vaccines, and anti-infective. 2. Animal Health-0 3. Segment Adjustment-This segment focuses on animal health, dairy, and poultry businesses. 4. Services-This segment conducts clinical trials, new product development, and undertakes data management for drug development.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹53,132 Cr | 34.2 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,028 Cr | 38.9 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹33,581 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹25,398 Cr | -77.7 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹23,578 Cr | 93 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹16,891 Cr | 26.4 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹16,525 Cr | 22.9 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,199 Cr | 24.2 | 18.07% | ₹873 Cr | -30.8% |
| Astrazeneca Pharma India Ltd. | ₹14,970 Cr | 79.8 | 22.82% | ₹683 Cr | -34.5% |
Listed by market capitalisation. Ratios are shown for context only.
Pfizer Ltd. is trading at ₹3,612.30, with a market capitalisation of ₹16,525 Cr.
Pfizer Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Pfizer Ltd. has a P/E of 22.9 and a return on equity of 17.16%.
Pfizer Ltd. is listed on the NSE under the symbol PFIZER and on the BSE under the scrip code 500680.
Pfizer Ltd.'s share price is down 32.1% over one year and down 21.9% over three months. Its 52-week range is ₹3,589.00 to ₹5,346.00.
In Q1 FY27, Pfizer Ltd. reported revenue of ₹653 Cr and net profit of ₹204 Cr, with basic EPS of ₹44.69 (standalone, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.